Key Developments: Advisory Board Co (ABCO.O)

ABCO.O on Nasdaq

49.96USD
17 May 2013
Price Change (% chg)

$0.85 (+1.73%)
Prev Close
$49.11
Open
$49.17
Day's High
$50.52
Day's Low
$49.17
Volume
327,416
Avg. Vol
296,274
52-wk High
$55.06
52-wk Low
$39.73

Search Stocks

Latest Key Developments (Source: Significant Developments)

Advisory Board Co Reaffirms CY 2013 Guidance
Thursday, 9 May 2013 04:36pm EDT 

Advisory Board Co reaffirmed previously announced calendar year 2013 guidance for revenue, adjusted EBITDA, and non-GAAP earnings per diluted share and expects revenue to be in a range of approximately $495 million to $505 million, adjusted EBITDA to be in a range of approximately $90 million to $95 million, and non-GAAP earnings per diluted share to be in a range of approximately $1.18 to $1.28.  Full Article

Advisory Board Co Announces Appointment Of Chiarman-Form 8-K
Monday, 8 Apr 2013 09:00pm EDT 

Advisory Board Co reported in its Form 8-K that On April 2, 2013, the Board of Directors (the Board) of The Advisory Board Company (the Company) appointed Robert W. Musslewhite, who currently serves as the Company’s Chief Executive Officer (CEO) and a director, to serve as the Chairman of the Board. The Company’s previous Chairman, Frank J. Williams, was appointed on that date to serve as Vice Chairman of the Board. Kelt Kindick will continue to serve as the independent Lead Director of the Board and will continue to have the duties and responsibilities set forth in the Company’s Corporate Governance Principles.  Full Article

Advisory Board Co Issues CY 2013 Guidance
Wednesday, 6 Feb 2013 04:10pm EST 

Advisory Board Co announced that it is providing financial guidance for calendar year 2013. For the calendar year, the Company expects revenue to be in a range of approximately $495 million to $505 million, adjusted EBITDA to be in a range of approximately $90 million to $95 million, and non-GAAP earnings per diluted share to be in a range of approximately $1.18 to $1.28. This guidance includes the dilutive effects of the acquisitions of ActiveStrategy and 360Fresh of approximately $6 million to $8 million in adjusted EBITDA and $0.11 to $0.16 in non-GAAP earnings per diluted share. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report  Full Article

Advisory Board Co Raises Low End Of Prior CY 2012 Revenue Guidance; Reaffirms CY 2012 Earnings Guidance
Thursday, 1 Nov 2012 04:19pm EDT 

Advisory Board Co announced that it is updating its revenue guidance for calendar year 2012 to a range of approximately $428 million to $432 million, up from a range of $426 million to $432 million. For calendar year 2012, the Company continues to expect adjusted EBITDA to be in a range of approximately $79 million to $82 million and non-GAAP earnings per diluted share to be in a range of approximately $1.20 to $1.25.  Full Article

The Advisory Board Company Raises CY 2012
Tuesday, 31 Jul 2012 04:15pm EDT 

The Advisory Board Company announced that for calendar year 2012, it expects revenue to a range of approximately $426-$432 million, adjusted EBITDA to a range of approximately $79-$82 million and non-GAAP earnings per diluted share (EPS) to a range of approximately $1.20-$1.25.  Full Article

The Advisory Board Company Reaffirms CY 2012 Guidance
Wednesday, 2 May 2012 04:15pm EDT 

The Advisory Board Company reaffirmed calendar year 2012 guidance for revenue, adjusted EBITDA, and non-GAAP earnings per diluted share. For calendar year 2012, the Company expects revenue to be in a range of approximately $420-$430 million, adjusted EBITDA to be in a range of approximately $77-$82 million, and non-GAAP earnings per diluted share to be in a range of approximately $2.40-$2.60.  Full Article

The Advisory Board Company Issues CY 2012 Guidance
Wednesday, 1 Feb 2012 04:50pm EST 

The Advisory Board Company announced that for calendar year 2012. it expects revenue to be in a range of approximately $420-$430 million, adjusted EBITDA to be in a range of approximately $77-$82 million and non-GAAP earnings per diluted share (EPS) to be in a range of approximately $2.40-$2.60. For calendar year 2012, the Company expects share-based compensation expense to be approximately $13.5 million, and expects amortization from acquisition-related intangible assets to be approximately $5 million.  Full Article

The Advisory Board Company Raises CY 2011 Guidance
Wednesday, 2 Nov 2011 04:10pm EDT 

The Advisory Board Company raised calendar year 2011 guidance and expects revenue to a range of approximately $349 million to $352 million, from a range of $342 million to $349 million. The Company is also increasing its guidance for calendar year 2011 adjusted EBITDA to a range of $61.5 million to $64.5 million, from a range of $60 million to $64 million. For calendar year 2011, the Company is increasing its guidance for non-GAAP earnings per diluted share (EPS) to a range of approximately $2.08 to $2.17, from a range of $2.00 to $2.13. According to I/B/E/S Estimates, analysts are expecting the Company to report EBITDA of $56 million for calendar year 2011.  Full Article

The Advisory Board Company Raises CY 2011 Guidance
Tuesday, 2 Aug 2011 04:16pm EDT 

The Advisory Board Company raised its revenue guidance for calendar year 2011 to a range of approximately $342 million to $349 million, up from a range of $318 million to $326 million. The Company is also raising its guidance for calendar year 2011 adjusted EBITDA to a range of $60 million to $64 million, up from a range of $56 million to $60 million. This guidance includes approximately $6 million to $7 million of revenue and $0.5 million of adjusted EBITDA from the acquisition of PivotHealth in calendar year 2011. For calendar year 2011, the Company is increasing its guidance for non-GAAP earnings per diluted share to a range of approximately $2.00 to $2.13, up from a range of $1.85 to $2.00.  Full Article

Search Stocks